179 related articles for article (PubMed ID: 35432200)
1. Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas.
Giuffrida G; D'Argenio V; Ferraù F; Lasorsa VA; Polito F; Aliquò F; Ragonese M; Cotta OR; Alessi Y; Oteri R; Di Maggio F; Asmundo A; Romeo PD; Spagnolo F; Pastore L; Angileri FF; Capasso M; Cannavò S; Aguennouz M
Front Endocrinol (Lausanne); 2022; 13():841118. PubMed ID: 35432200
[TBL] [Abstract][Full Text] [Related]
2. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
[TBL] [Abstract][Full Text] [Related]
3. Integrating Methylome and Transcriptome Signatures Expands the Molecular Classification of the Pituitary Tumors.
Silva-Júnior RMPD; Bueno AC; Martins CS; Coelli-Lacchini F; Ozaki JGO; Almeida-E-Silva DC; Marrero-Gutiérrez J; Santos ACD; Garcia-Peral C; Machado HR; Santos MVD; Elias PL; Moreira AC; Colli LM; Vêncio RZN; Antonini SR; de Castro M
J Clin Endocrinol Metab; 2023 May; 108(6):1452-1463. PubMed ID: 36504388
[TBL] [Abstract][Full Text] [Related]
4. Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma.
Ashton C; Rhie SK; Carmichael JD; Zada G
J Neurosurg; 2020 Feb; 134(3):787-793. PubMed ID: 32109873
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation profiling in nonfunctioning pituitary adenomas.
Kober P; Boresowicz J; Rusetska N; Maksymowicz M; Goryca K; Kunicki J; Bonicki W; Siedlecki JA; Bujko M
Mol Cell Endocrinol; 2018 Sep; 473():194-204. PubMed ID: 29410024
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior.
Vicchio TM; Aliquò F; Ruggeri RM; Ragonese M; Giuffrida G; Cotta OR; Spagnolo F; Torre ML; Alibrandi A; Asmundo A; Angileri FF; Esposito F; Polito F; Oteri R; Aguennouz MH; Cannavò S; Ferraù F
J Endocrinol Invest; 2020 Jul; 43(7):947-958. PubMed ID: 31939196
[TBL] [Abstract][Full Text] [Related]
7. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas.
Gejman R; Batista DL; Zhong Y; Zhou Y; Zhang X; Swearingen B; Stratakis CA; Hedley-Whyte ET; Klibanski A
J Clin Endocrinol Metab; 2008 Oct; 93(10):4119-25. PubMed ID: 18628527
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly.
Neto LV; Machado Ede O; Luque RM; Taboada GF; Marcondes JB; Chimelli LM; Quintella LP; Niemeyer P; de Carvalho DP; Kineman RD; Gadelha MR
J Clin Endocrinol Metab; 2009 Jun; 94(6):1931-7. PubMed ID: 19293270
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of microRNAs in GH-secreting pituitary adenomas.
Mao ZG; He DS; Zhou J; Yao B; Xiao WW; Chen CH; Zhu YH; Wang HJ
Diagn Pathol; 2010 Dec; 5():79. PubMed ID: 21138567
[TBL] [Abstract][Full Text] [Related]
11. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
[TBL] [Abstract][Full Text] [Related]
12. Non-functioning pituitary adenomas: growth and aggressiveness.
Øystese KA; Evang JA; Bollerslev J
Endocrine; 2016 Jul; 53(1):28-34. PubMed ID: 27066792
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas.
Grande IPP; Amorim PVGH; Freire ACTB; Jallad RS; Musolino NR; Cescato VA; da Silva GO; Bronstein MD; Trarbach EB
Pituitary; 2018 Aug; 21(4):355-361. PubMed ID: 29564694
[TBL] [Abstract][Full Text] [Related]
14. Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
Chen Y; Gao H; Xie W; Guo J; Fang Q; Zhao P; Liu C; Zhu H; Wang Z; Wang J; Gui S; Zhang Y; Li C
Aging (Albany NY); 2020 Dec; 13(1):1276-1293. PubMed ID: 33472173
[TBL] [Abstract][Full Text] [Related]
15. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
16. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas.
Shirian FI; Ghorbani M; Khamseh ME; Imani M; Panahi M; Alimohammadi A; Nourbakhsh M; Salimi V; Tavakoli-Yaraki M
BMC Endocr Disord; 2021 Mar; 21(1):50. PubMed ID: 33736633
[TBL] [Abstract][Full Text] [Related]
18. Early recognition of aggressive pituitary adenomas: a single-centre experience.
Ceccato F; Regazzo D; Barbot M; Denaro L; Emanuelli E; Borsetto D; Rolma G; Alessio L; Gardiman MP; Lombardi G; Albiger N; D'Avella D; Scaroni C
Acta Neurochir (Wien); 2018 Jan; 160(1):49-55. PubMed ID: 29170844
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
Lampropoulos KI; Samonis G; Nomikos P
Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas.
Ruebel KH; Jin L; Zhang S; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(3):281-9. PubMed ID: 11740049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]